Pipeline
A pipeline rich in possibilities
Built on deep neuroscience expertise, AviadoBio is developing targeted, one-time gene therapies to precisely deliver genetic medicines to disease-relevant cells and pathways within the nervous system, restoring function and hope through advanced science.
Our proprietary platforms, including intrathalamic and vMiX™ RNA silencing system, plus expertise in intravitreal, and blood-brain barrier (BBB)-penetrant delivery approaches, enable precise, durable therapeutic expression across complex neural systems such as the brain and retina. AviadoBio’s clinical and preclinical pipeline spans frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), inherited retinal diseases, and tauopathies, including Alzheimer’s disease.
We believe delivery to be the gamechanger in overcoming challenges with existing treatment pathways.
Transformative technology
Alex Bloom, Chief Technology Officer, discusses how AviadoBio is solving some of the most significant technical challenges in the field.
Focused on advancing a pipeline of targeted gene therapies
Science and innovation
Find out more about how we are progressing innovative gene therapies to treat neurodegenerative disease.